Cath Lab

The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).

CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and medical imaging companies for the first time at the Radiological Society of North America (RSNA) 2019 meeting. With technology platforms that integrate modeled human physiology into immersive, augmented reality environments, CAE Healthcare partners with vendors to deliver risk-free training solutions that meet the needs of physicians and equipment providers. #RSNA19 #RSNA2019
News | Virtual and Augmented Reality
Augmented Reality for Radiology and Cardiology Training Demonstrated at RSNA 2019

November 27, 2019 — CAE Healthcare will showcase its mixed reality training solutions for practicing physicians and ...

Home November 27, 2019
Home
A sample of the transcatheter mitral valve replacement (TMVR) devices in development or clinical trials.
Feature | Heart Valve Technology | Saipriya Iyer
Developments in Transcatheter Mitral Valve Replacement

The overwhelming success story for transcatheter aortic valve replacement (TAVR) moving from a science project to ...

Home November 27, 2019
Home
A key slide from the TRILUMINATE study one-year results showing the improvement in tricuspid regurgitation from basement with treatment using the transcatheter TriClip device.
News | Heart Valve Technology | Dave Fornell, Editor
TriClip Device For Tricuspid Regurgitation Effective at One Year in TRILUMINATE Study

November 26, 2019 — The preliminary one-year results of the TRILUMINATE Pivotal Study for Abbott's TriClip device, a ...

Home November 26, 2019
Home
The FDA cleared the IN.PACT AV drug-coated Balloon. Clinical data shows In.Pact AV DCB is Safe, reduces reinterventions and maintains access for end-stage renal disease patients undergoing dialysis
News
FDA Clears Medtronic Drug-Coated Balloon to Treat Arteriovenous Fistula Lesions

November 21, 2019 — The U.S. Food and Drug Administration (FDA) has cleared the Medtronic In.Pact AV drug-coated balloon ...

Home November 26, 2019
Home
The percentage of women entering the cardiology workforce is low, despite the fact that half of all medical students are women. Despite the low numbers, many women have become luminaries in the field of cardiology, including Dee Dee Wang, M.D., director of advanced cardiovascular imaging at Henry Ford Hospital, pictured here.
Blog | Cardiovascular Business
Women: Cardiology Needs You!

Now, more than ever, the field of cardiology needs women. 


But as the national need for more cardiologists overall ...

Home November 22, 2019
Home
The three sites most often used for distal radial artery access are the (1) anatomic snuffbox above the scaphoid (left), (2) adjacent to the snuffbox at the trapezium bone (center), and (3) the first intermetacarpal space (right). The author’s preference is either of the first two options, although good outcomes have been reported with use of the intermetacarpal space.
Feature | Radial Access | Enrique Flores, M.D., RPVI
Incorporating Distal Radial Artery Access Into Clinical Practice
Interest in distal radial artery access (DRA) is growing rapidly. Among the benefits of DRA are the low risk of entry ...
Home November 21, 2019
Home
In the ISCHEMIA study, patients were randomized into one of two groups: a conservative strategy or an invasive strategy. Illustration by NYU Langone staff
Feature | AHA
ISCHEMIA Trial Results Find Interventions for Stable Heart Disease No better Than Drug Therapy

November 19, 2019 — After 12 years of collecting data, the results of the landmark ISCHEMIA (International Study of ...

Home November 19, 2019
Home
Since Maquet/Datascope first recalled all of its intra-aortic balloon pumps (IABP) due to reports of the batteries failing in November 2018, a year later the U.S. Food and Drug Administration said its has received more than 60 additional medical device reports related to this issue. These included two patient deaths and one serious patient injury.
News
Over 60 New Safety Reports Filed With FDA for Maquet IABPs Turning Off During Use

November 19, 2019 — Since Maquet/Datascope first recalled all of its  intra-aortic balloon pumps (IABP) due to reports ...

Home November 19, 2019
Home
The American Heart Association, AHA, 2019 meeting late breaking trials and key studies on cardiovascular science.
Feature | AHA | Dave Fornell, Editor
American Heart Association 2019 Late-breaking Trials

November 19, 2019 — Here is a list of the key late-breaking clinical study presentations and links to the results at the ...

Home November 19, 2019
Home
The ClotTriever system (Inari Medical), a mechanical thrombectomy system FDA 510(k) cleared for the nonsurgical removal of soft thrombi and emboli from peripheral blood vessels. #VIVA19 #VIVA2019
News | Deep Vein Thrombosis (DVT)
DVT ClotTriever (CLOUT) Registry Shows Significant Improvement

November 7, 2019 — The ClotTriever Outcomes (CLOUT) Registry is evaluating real-world patient outcomes following ...

Home November 14, 2019
Home
News | Peripheral Artery Disease (PAD)
The ULYSSE Registry Shows Benefit of Ultrasoundplasty Before Below-the-knee Interventions

November 7, 2019 — Ultrasoundplasty before angioplasty for below-the-knee lesions (BTK) lesions may improve clinical ...

Home November 14, 2019
Home
News | Peripheral Artery Disease (PAD)
Adventitial Temsirolimus Injections in BTK Lesions Improved Outcomes in TANGO Trial

November 14, 2019 — There were positive results in the TANGO Trial is a phase 2, dose escalation, double-blinded trial ...

Home November 14, 2019
Home
The LimFlow procedure permanently bypasses unreconstructable arteries and leverages healthier veins as a conduit to create new routes to perfuse tissue in the foot. #VIVA #VIVA19 #VIVA2019
News | Peripheral Artery Disease (PAD)
LimFlow Procedure Successful in Bypassing Unreconstructable Arteries in Limb-threatening Ischemia

November 14, 2019 — Results were positive for the multicenter PROMISE I Trial represents the first human use in the ...

Home November 14, 2019
Home
The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the Medtronic IN.PACT AV Access drug-coated balloon (DCB) met both of its endpoints, in data presented at the 2019 Vascular Interventional Advances (VIVA) annual meeting. #VIVA #VIVA19 #VIVA2019
News | Drug-Eluting Balloons
IN.PACT AV Access 6-Month Data Show Increased Vessel Patency

November 7, 2019 — The IN.PACT Arteriovenous (AV) Access randomized trial evaluating the safety and effectiveness of the ...

Home November 14, 2019
Home
The Rex Medical Revolution rotational atherectomy system incorporates continuous aspiration and has a dual indication for atherectomy and thrombectomy. #VICA19 #VIVA2019
News | Atherectomy Devices
Revolution Rotational Atherectomy System Effective in IDE Experience

November 7, 2019 — The REVEAL FDA investigational device exemption (IDE) trial confirmed a favorable safety and ...

Home November 11, 2019
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now